CIK 0001622229 · Large accelerated filer
Cogent Biosciences, Inc.
Sign in to watch- Ticker
- COGT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 465308248
- Phone
- 617-945-5576
- Business address
- 180 THIRD AVENUE, 4TH FLOOR, WALTHAM, MA
- Former names
- Unum Therapeutics Inc., Unum Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,689,493
- in 1 filing, $1.7M under 10b5-1 plans
Net −$1,689,493. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-07-10 | Fairmount Funds Management LLC Director | Purchase | +2,777,777 | $9.00 | $25.0M | 9,003,418 |
| 2025-01-14 | Pinnow Cole Chief Commercial Officer | Purchase | +43,750 | $7.60 | $332K | 45,848 |
| 2023-06-09 | Fairmount Funds Management LLC 10% owner | Purchase | +800,000 | $12.00 | $9.6M | 3,272,124 |
| 2022-06-16 | Fairmount Funds Management LLC 10% owner | Purchase | +1,200,000 | $8.25 | $9.9M | 2,472,124 |
Page 1 of 1 · 4 trades